|
LASS6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.638000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.370400E-01 |
| Normal-vs-Stage2 |
2.985400E-01 |
| Normal-vs-Stage3 |
2.015600E-01 |
| Normal-vs-Stage4 |
6.122200E-01 |
| Stage1-vs-Stage2 |
2.837800E-01 |
| Stage1-vs-Stage3 |
9.432100E-02 |
| Stage1-vs-Stage4 |
5.446200E-01 |
| Stage2-vs-Stage3 |
5.448000E-02 |
| Stage2-vs-Stage4 |
1.825250E-01 |
| Stage3-vs-Stage4 |
5.271600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.090600E-01 |
| Normal-vs-AfricanAmerican |
3.878000E-01 |
| Normal-vs-Asian |
7.823200E-01 |
| Caucasian-vs-AfricanAmerican |
1.220360E-01 |
| Caucasian-vs-Asian |
4.095600E-01 |
| AfricanAmerican-vs-Asian |
5.951200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.575170E-01 |
| Normal-vs-Female |
6.939800E-01 |
| Male-vs-Female |
1.351630E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.399800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.778400E-01 |
| Normal-vs-Age(61-80Yrs) |
9.104800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.218500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.692750E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.641400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.098380E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.711600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.202200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.790770E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.002800E-03 |
| Classical-VS-Follicular |
3.077600E-01 |
| Classical-VS-Other |
6.205800E-02 |
| Classical-VS-Normal |
9.103800E-01 |
| Tall-VS-Follicular |
1.998430E-03 |
| Tall-VS-Other |
3.117800E-01 |
| Tall-VS-Normal |
1.957900E-02 |
| Follicular-VS-Other |
8.098300E-02 |
| Follicular-VS-Normal |
3.462000E-01 |
| Other-VS-Normal |
3.152200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.642800E-01 |
| Normal-vs-N1 |
3.208200E-01 |
| N0-vs-N1 |
3.189800E-01 |
|
|
